CELGENE CORP /DE/'s Net Worth

$268 Million

Estimate Recalculated Jul 10, 2024 03:14PM EST

Who is CELGENE CORP /DE/?

CELGENE CORP /DE/ has an estimated net worth of $268 Million. This is based on reported shares across multiple companies, which include ACCELERON PHARMA INC, Alliqua BioMedical, Inc., AGIOS PHARMACEUTICALS, INC., Jounce Therapeutics, Inc., SUTRO BIOPHARMA INC, CRISPR Therapeutics AG, Epizyme, Inc., Abraxis BioScience, Inc., GLOBEIMMUNE INC, Juno Therapeutics, Inc., Receptos, Inc., and ENTREMED INC.

SEC CIK

CELGENE CORP /DE/'s CIK is 0000816284

Past Insider Trading and Trends

2014 was CELGENE CORP /DE/'s most active year for acquiring shares with 10 total transactions. CELGENE CORP /DE/'s most active month to acquire stocks was the month of June. 2017 was CELGENE CORP /DE/'s most active year for disposing of shares, totalling 21 transactions. CELGENE CORP /DE/'s most active month to dispose stocks was the month of October. 2018 saw CELGENE CORP /DE/ paying a total of $114,054,636.00 for 3,428,505 shares, this is the most they've acquired in one year. In 2017 CELGENE CORP /DE/ cashed out on 11,480,546 shares for a total of $19,578,120.42, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Alliqua BioMedical, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+4.20%
296.28K
—
—
7.34M
Apr 11
Form 4
+131.32%
4M
$0.50
$2,000,000.00
7.05M
Feb 27
Form 4
+27.62%
659.34K
$4.55
$2,999,997.00
3.05M
May 4
Form 4
+42.71%
714.29K
$7.00
$5,000,002.00
2.39M
Apr 14
Form 3
—
0
—
—
0
No matching records found

AGIOS PHARMACEUTICALS, INC. (AGIO) Snapshot price: $24.15

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+29.33%
403.23K
$31.00
$12,499,975.00
1.78M
Nov 12
Form 4/A
+162.61%
851.15K
$67.00
$57,027,318.00
1.37M
Jan 23
Form 4
+162.61%
851.15K
$67.00
$57,027,318.00
1.37M
Jan 23
Form 4
+50.71%
624.58K
$49.50
$30,916,462.50
1.86M
Apr 24
Form 4
+41.62%
294.8K
$44.00
$12,971,200.00
1M
Apr 29
Form 4
∞
4.72M
$18.00
$12,749,994.00
4.72M
Jul 29
Form 3
—
0
—
—
0
No matching records found

ACCELERON PHARMA INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.53%
36.74K
$54.08
-$12.96
7.01M
Jul 9
Form 4
+1.58%
108.11K
$92.50
$9,999,990.00
6.97M
Jul 1
Form 4
+11.54%
706.21K
$43.00
$30,366,858.00
6.82M
Jan 18
Form 4
+13.88%
745.59K
$37.00
$27,586,904.00
6.12M
Sep 25
Form 4
+17.49%
800K
$40.00
$32,000,000.00
5.37M
Jan 11
Form 4
+31.67%
1.1M
$42.86
$47,146,000.00
4.57M
May 5
Form 4
+9.46%
300K
$50.00
$15,000,000.00
3.47M
Jan 28
Form 4
∞
3.17M
$15.00
—
3.17M
Sep 24
Form 3
—
0
—
—
0
No matching records found

Jounce Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.46M
$16.00
—
3.46M
Feb 1
Form 3
—
0
—
—
0
No matching records found

SUTRO BIOPHARMA INC (STRO) Snapshot price: $4.67

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.73M
—
—
1.73M
Oct 1
Form 3
—
0
—
—
0
No matching records found